Effects of Perfluorooctanoic Acid Exposure during Pregnancy in the Mouse

• Published in: Toxicological sciences 2006-04, Vol.90 (2), p.510-518
• Main Authors: Lau, Christopher, Thibodeaux, Julie R., Hanson, Roger G., Narotsky, Michael G., Rogers, John M., Lindstrom, Andrew B., Strynar, Mark J.
• Format: Article
• Language: English
• Subjects: Animals; Animals, Newborn - growth & development; Caprylates - blood; Caprylates - pharmacokinetics; Caprylates - toxicity; developmental toxicity; Female; Fetal Development - drug effects; Fluorocarbons - blood; Fluorocarbons - pharmacokinetics; Fluorocarbons - toxicity; Male; Mice; Mice, Inbred Strains; perfluorooctanoic acid; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Sex Factors; Species Specificity
• ISSN: 1096-6080; 1096-0929
• DOI: 10.1093/toxsci/kfj105

Perfluorooctanoic acid (PFOA), a member of the perfluoroalkyl acids that have wide commercial applications, has recently been detected in humans and wildlife. The current study characterizes the developmental toxicity of PFOA in the mouse. Timed-pregnant CD-1 mice were given 1, 3, 5, 10, 20, or 40 mg/kg PFOA by oral gavage daily from gestational day (GD) 1 to 17; controls received an equivalent volume (10 ml/kg) of water. PFOA treatment produced dose-dependent full-litter resorptions; all dams in the 40-mg/kg group resorbed their litters. Weight gain in dams that carried pregnancy to term was significantly lower in the 20-mg/kg group. At GD 18, some dams were sacrificed for maternal and fetal examinations (group A), and the rest were treated once more with PFOA and allowed to give birth (group B). Postnatal survival, growth, and development of the offspring were monitored. PFOA induced enlarged liver in group A dams at all dosages, but did not alter the number of implantations. The percent of live fetuses was lower only in the 20-mg/kg group (74 vs. 94% in controls), and fetal weight was also significantly lower in this group. However, no significant increase in malformations was noted in any treatment group. The incidence of live birth in group B mice was significantly lowered by PFOA: ca. 70% for the 10- and 20-mg/kg groups compared to 96% for controls. Postnatal survival was severely compromised at 10 or 20 mg/kg, and moderately so at 5 mg/kg. Dose-dependent growth deficits were detected in all PFOA-treated litters except the 1-mg/kg group. Significant delays in eye-opening (up to 2–3 days) were noted at 5 mg/kg and higher dosages. Accelerated sexual maturation was observed in male offspring, but not in females. These data indicate maternal and developmental toxicity of PFOA in the mouse, leading to early pregnancy loss, compromised postnatal survival, delays in general growth and development, and sex-specific alterations in pubertal maturation.